Jian-Feng (Jeff) Lu, Ph.D. – President and CEO
Jeff Lu, Ph.D., has been President and Chief Executive Officer of AskGene Pharma since its inception. Dr. Lu has more than 25 years of experience in clinical pharmacology including more than 12 years of experience in PK/PD and drug development across various therapeutic areas at Genentech and Amgen. Dr. Lu’s previous posts included Consulting Director at Quantitative Solution and increasing responsibility up to Scientific Director at Amgen. During his tenure, he participated in the first BLA filing of Avastin and the first NDA filing of Tarceva. Additionally, Dr. Lu was responsible for PK/PD assessment, dose selection, and study design for many projects ranging from pre-clinical stage through phase III, which included biologics, small molecule and antibody-drug conjugate programs. Dr. Lu received his Ph.D. in Pharmaceutics from China Pharmaceutical University and completed his post-doctoral training at the University of California San Francisco (UCSF). Dr. Lu is a guest professor at Jiangnan University. Dr. Lu was also invited to draft the biosimilar guidance for CFDA.